Nuance Pharma
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A commercial-stage company developing and marketing innovative biologics for respiratory and cardiovascular diseases.
RespiratoryCardiovascular
Technology Platform
A development and commercialization platform focused on novel biologics, with capabilities in clinical development, regulatory strategy, and go-to-market execution.
Opportunities
Leveraging China's large patient base and growing healthcare investment to commercialize innovative biologics for chronic diseases.
Risk Factors
Commercial execution risk and potential pricing pressure from national reimbursement negotiations in China.
Competitive Landscape
Competes with large multinational pharma and domestic giants in the crowded but high-growth respiratory and cardiovascular biologics markets.